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Abstract
Nowadays there is a substantial practical interest in the in vitro bioactivity of calcium silicate phosphate
(CSP) glass-ceramics and carbonate apatite (CO3HA) formation on their surfaces after in vitro test in simu-
lated body ﬂuid (SBF). The main purpose of the presentedarticle is the evaluation of the chemical composition
of the gel with nominal composition 70.59 CaO:28.23 SiO2:1.18 P2O5 (mol.%) on the structure, crystalliza-
tion behaviour and in vitro bioactivity in SBF solution for 14 and 28 days. The prepared glass-ceramics have
been synthesized via a polystep sol-gel method. The structure of the obtaining samples was studied by X-ray
diﬀraction (XRD) analysis, Fourier transform infrared spectroscopy(FTIR) and scanning electron microscopy
with energydispersive X-ray spectroscopy(SEM-EDX). After thermal treatment of the samples XRD conﬁrmed
the presence of β-Ca2SiO4 and Ca15(PO4)2(SiO4)6, and indicated that at 1500°C Ca15(PO4)2(SiO4)6 becomes
predominant phase. FTIR revealed the presence of all characteristics bands for calcium silicate phosphate
(CSP) bonds. SEM monitors the presence of particles with diﬀerent morphology. After in vitro test in SBF,
FTIR depicted that B-type carbonate containing hydroxyapatite (CO3HA) is preferentially formed on the im-
mersedglass-ceramics.SEM of the precipitatedlayers showedthe presenceof HA spheres.The changesin SBF
solution after soaking the samples were recorded by inductively coupled plasma atomic emission spectroscopy
(ICP-AES).
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I. Introduction
It is well known that hydroxyapatite, HA
(Ca10(PO4)6(OH)2) exhibits beneﬁcial properties
as biomaterial, such as biocompatibility, osteoconduc-
tivity and good ability to bond directly to bone [1]. It is
also known that HA shows a limited in vitro and in vivo
reactivity. To solve this problem many research groups
synthesized silicon substituted HA, Si-HA [2–7], due
to the known role and inﬂuence of silicon on the new
bone formation [8]. Based on these observations, some
researchers [9,10] suggested that the HA forming
ability at diﬀerent glass-ceramics in CaO-SiO2-P2O5
system could be measured in solutions of SBF, and the
ability of biomaterials in formation of CO3HA on the
surface of the immersed samples.
In vitro bioactive glass-ceramics have been synthe-
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sized by our research team in two systems CaO-SiO2-
P2O5 [11] and CaO-SiO2-P2O5-MgO [12] with diﬀer-
ent Ca/(P+Si) or (Ca+Mg)/(P+Si) molar ratio. On the
basis of the obtained results we can summarize that
Ca5(PO4)2SiO4 (silicocarnotite) was synthesized after
thermal treatment at 1200°C for 2 hours when molar
ratio Ca/(P+Si) = 1.67, and Ca15(PO4)2(SiO4)6 (cal-
cium phosphate silicate), α-CaSiO3 (wollastonite) and
β-CaSiO3 phases were denoted when Ca/(P+Si) = 1.89,
[11]. Furthermore, in the case of MgO containing sam-
ples we producedtwo types of glass-ceramics as a func-
tion of (Ca+Mg)/(P+Si) molar ratio. When this ratio
was 1.68 Ca2MgSi2O7 (akermanite) and HA were ob-
served. On the contrary, when this molar ratio was 2.16
(Ca Mg)3(PO4)2 (calcium magnesium phosphate) and
Ca5(PO4)2SiO4 were detected[12]. It was also observed
that the synthesized glass ceramics were in vitro bioac-
tive after soaking in SBF solution in static conditions
for diﬀerent periods of time. In the other article [13]
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we evaluated the relation between the quantity of P2O5
in the CaO-SiO2-P2O5 system on the crystalline phases
observed and for the in vitro bioactivity. On the ba-
sis of the experimental results we concluded that in
the sample Ca15(PO4)2(SiO4)6, Ca2SiO4 (dicalcium si-
licate) and Ca3(PO4)2 (TCP) were observed. Brieﬂy, in
the CaO-SiO2-P2O5 (MgO) systems, in vitro bioactive
polycrystalline samples have been synthesized.
In the series of our papers, we also evaluated the pos-
sibility to obtain some in vitro bioactive composites be-
tween the synthesized glass-ceramics and some natu-
ral biodegradable polymers, such as collagen [14–16],
gelatin [17,18], and ﬁbroin [19]. Based on the obtained
results it can be assumed that all synthesized compos-
ites exhibit good in vitro bioactivity, and they oﬀer a
promising way for creation of new bioimplants.
The aim of the presented study was to synthesize
glass-ceramic in the CaO-SiO2-P2O5 system and to
evaluate their in vitro bioactivity in SBF solution for 14
and 28 days in static conditions.
II. Experimental
2.1. Materials
All chemicals used for modiﬁed sol-gel synthe-
sis were reagent grade, tetraethylorthosilicate (TEOS,
Fluka, Switzerland), calcium oxide (CaO, Merck, Ger-
many), 85% phosphoric acid (H3PO4, Merck, Ger-
many), 37% hydrochloric acid (HCl, Merck, Ger-
many),37%ammonia(NH3,Merck,Germany).Ethanol
(C2H5OH, Fluka, Switzerland) and deionized water,
served as solvents in this study.
2.2. Sol-gel synthesis
The ceramic material in CaO-P2O5-SiO2 system has
been synthesized via polystep sol-gel method. The
chemicalcompositionof thepreparedsolis describedas
70.59 CaO:28.23 SiO2 : 1.18 P2O5 (mol%). Sol A was
obtained by appropriate amounts of Ca(OH)2 and SiO2.
Silica sol was produced by prehydrolyzation of TEOS
in the presence of C2H5OH, H2O and HCl in molar ra-
tio C2H5OH : H2O : HCl = 1 : 1 : 4 : 0.01. Ca(OH)2
was prepared by dissolution of CaO in deionized water
under stirring. After recognizing the SiO2 and Ca(OH)2
solutions, Ca(OH)2 was mixed “drop by drop” to the
transparent SiO2 sol under stirring. The obtained mixed
sol A was intensively stirred for 4 hours. The sol B
contains two components Ca(OH)2 and H3PO4. As it
was written above Ca(OH)2 was obtained from CaO
and deionized water in the appropriate amounts. The
required amount of H3PO4 was added to Ca(OH)2 so-
lution carefully under stirring for 4 hours. 25% NH4OH
was used to obtain pH = 10–11 of mixed calcium phos-
phate (CP) solution. The sol B was added from the bu-
rette to the sol A under stirring for 20 hours to pro-
duce CSP solution. The obtained mixed sol was gelated
at 120°C for 12 hours and thermally treated at diﬀer-
ent temperatures (1200, 1300, 1400 and 1500°C) for 2
hours. Thus, the synthesized samples were labelled as
CSP 1200, CSP 1300, CSP 1400 and CSP 1500 in ac-
cordance with the temperature of treatment of the dried
gels.
2.3. In vitro bioactivity test
Bioactivity of the obtained ceramic materials was
evaluated by examining the apatite formation on their
surfaces in SBF in accordance with Kokubo et al.
The SBF solution was prepared with 7.996g
NaCl, 0.350g NaHCO3, 0.224g KCl, 0.228g
K2HPO4×3H2O, 0.305g MgCl2×6H2O, 0.278g
CaCl2, 0.071g Na2SO4, and buﬀering at pH = 7.4 at
36.5°C with TRIS = 6.057g and 1M HCl in deionized
water.
The synthesized ceramic powder was pressed at
50MPa with PVA, as a binder, to obtain disc specimens
(12mm diameter and 2mm thick) and immersed in SBF
at the human body temperature (36.6°C) in polyethy-
lene bottles in static conditions for 14 and 28 days. A
few drops of 0.5% sodium azide (NaN3) were added
to the SBF solution to inhibit the growth of bacteria
[21,22]. After soaking, the specimens were removed
from the ﬂuid and gently rinsed with distilled water, and
then dried at 36.6°C for 12h.
2.4. Characterization
The structure and in vitro bioactivity of synthesized
glass-ceramics were monitored by XRD, FTIR and
SEM.
XRD were collected within the range from 10 to 80°
2θ with a constant step 0.04° 2θ and counting time
1s/step on Brucker D8 Advance diﬀractometer with
CuKα radiation and SolX detector. FTIR transmission
spectra were recorded by using a Brucker Tensor 27
Spectrometer with scanner velocity 10kHz. KBr pel-
lets were prepared by mixing ∼1mg of the sample with
300mg KBr. Transmission spectra were recorded using
MCT detector with 64 scans and 1cm-1 resolution.
SEM (SEM, Hitachi, TM3000) at an operating volt-
age of 15kV and EDX were used to study morphology
and Ca/(P+Si) ratio of the apatite formed on the surface
of bioactive glass-ceramic samples.
The ion concentrations of Ca, P and Si before and
after soaking in SBF for 14 and 28 days were recorded
by ICP-AES using IRIS 1000, Thermo elemental, USA.
III. Results and discussion
XRD patterns of the synthesized sample, thermally
treated at diﬀerent temperatures, are given in Fig. 1.
In the sample treated at 1200°C XRD conﬁrmed
the presence of crystalline maxima corresponding to β-
Ca2SiO4 (PDF card 86-0398) and Ca15(PO4)2(SiO4)6
(PDF card 83-1494). β-Ca2SiO4 was a predominant
phase, and Ca15(PO4)2(SiO4)6 became an accompa-
nying phase. XRD patterns of the samples treated
at 1300 and 1400°C also show the presence of
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Figure 1. XRD of thermally treated CSP samples at 1200°C,
1300°C, 1400°C and 1500°C for 2 hours
Figure 2. FTIR spectra of CSP 1200 (a), CSP 1300 (b), CSP
1400 (c) and CSP 1500 (d) samples
β-Ca2SiO4 and Ca15(PO4)2(SiO4)6. In these samples
β-Ca2SiO4 is also predominant phase. However, at
1500°C Ca15(PO4)2(SiO4)6 becomes predominant and
β-Ca2SiO4 is accompanied phase.
FTIR spectra of the CSP glass-ceramics before soak-
ing in SBF aregivenat Fig. 2.The presentedFTIR spec-
tra show the absorption bands corresponding to the dif-
ferent vibration modes of the Si−O bonds. The bands,
posited at ∼990cm-1 can be assigned to the Si−O−Si
asymmetricstretchwhereasthebandsat∼910–880cm-1
to the Si−O symmetric strange [2,23,24]. The band
at ∼520cm-1 could be ascribed to the Si−O−Si vibra-
tional mode of bending. In accordance with some pre-
liminary results, these bands could be related to the β-
Ca2SiO4 [23,25,26]. A doublet with small intensity at
∼530–610cm-1 can also been observed. This doublet is
characteristic of crystalline calcium phosphate(CP) and
is probably due to the presence of Ca15(PO4)2(SiO4)6
crystal phases, formed in the prepared samples [27].
The band, centred at ∼1100cm-1 can be assigned to
the presence of ν4PO4
3– groups [9]. In accordance with
our preliminary results, the bands posited at ∼1530–
1360cm-1 and at ∼840cm-1 could be ascribed to the
ν3 and ν2 CO3
2– [13]. The presence of these bands is
attributed to a partial carbonation process of the syn-
thesized glass-ceramics due to the atmospheric CO2
as a consequence of high calcium content in the pre-
paredsamples.This phenomenonwas observedby Mar-
tinez et al. [28] for CaO-SiO2 sol-gel glasses. In our
preliminary studies we also observed the presence of
CO3
2– bond in the prepared ceramics in the presence
of Ca15(PO4)2(SiO4)6 as a main phase [11]. The ob-
tained results indicated that the glass-ceramic materials
consistingCa15(PO4)2(SiO4)6 must be kept out of atmo-
sphere in a desiccator. Surprisingly, in the FTIR spectra
of the synthesized samples treated at diﬀerent tempera-
tures the characteristic bands of CaCO3 could be iden-
tiﬁed. This fact allows us to conclude that under car-
bonization process the role of atmospheric CO2 could
be expressed for the formation of carbonate substituted
crystalline calcium phosphates.
FTIR spectra of the obtained glass-ceramics after
soaking in SBF solution for 14 and 28 days are given
in Figs. 3 and 4.
Figure 3. FTIR spectra of CSP 1200 (a), CSP 1300 (b), CSP
1400 (c) and CSP 1500 (d) samples after
in vitro test for 14 days
Figure 4. FTIR spectra of CSP 1200 (a), CSP 1300 (b), CSP
1400 (c) and CSP 1500 (d) samples after
in vitro test for 28 days
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For the precipitates, the observed absorption peaks
showed that these were typical spectra for the carbon-
ated hydroxyapatite,conﬁrming that the precipitates are
CO3HA [29].
Theoretically, four vibration modes are expected for
the phosphate ions in the HA spectra: ν1 PO4
3– at
961–965cm-1, ν2 PO4
3– at 460cm-1, ν3 PO4
3– at 1190–
980cm-1 and ν4 PO4
3– at 660–520cm-1 [30,31]. In
our case, three new peaks at ∼651cm-1 (labeled as ￿)
[10,32], ∼602cm-1 (labeled as ￿) [33–45], and 560cm-1
(labeled as N) [3,32–45] could be ascribed to the ν4
PO4
3–. The peaks at ∼453cm-1 (labeled as ￿) could be
related to the PO4
3– and Si−O−Si [46–48]. ν3 PO4
3–
are visible from the absorption bands, posited at 995–
997cm-1 for all samples [49,50]. A phosphate vibra-
tion ν1 PO4
3– is observed in the discrete visible peak
at ∼940cm-1, while ν2 PO4
3– is visible at ∼460cm-1 for
all samples [30].
It was very interesting and surprising that we did not
observe the presence of intensive absorption band for
CO3
2– ion at ∼875–878cm-1 which is indicative for all
CO3HA structures [51]. From the depicted FTIR re-
sults, it is seen that in our case CO3
2– could be observed
at ∼842cm-1 as an intensive band. In accordance with
Regnier et al. [52], the observed peak can be ascribed
to the carbonate ion in the crystalline calcium phos-
phate lattice. Ilmen et al. [53] noted that the peaks in
the region 842–910cm-1 could be related to the ν2 out-
of-planevibrationof CO3
2– in the threeforms of CaCO3
- calcite, aragonite and vaterite.
On the basis of the obtained FTIR results, we con-
clude that the crystalline calcium phosphates may be
formed on the soaked surface after 14 and 28 days.
Furthermore, in the presented FTIR data we could
also observe the presence of intensive bands in the
region ∼1580–1360cm-1. These peaks could be de-
noted as CO3
2– [3,29,33,35,36,38–41,44,46,47,54–57],
thus, their presence showed that the crystalline calcium
phosphates could be related to CO3HA. The bands at
∼1634cm-1 are related to the H2O in the soaked glass-
ceramics [29,57].
It is well known that the apatite structure depends
on its chemical compositions. There are two types of
substitutions into HA lattice: CO3
2– can replace PO4
3–
ions (B-type) and CO3
2– can replace OH– ions (A-type)
[52,58–61]. For more detailed information about the
type of substitution in CO3HA formed on the surface
of CSP samples after immersion in SBF solution for 14
and 28 days, the analysis by curve-ﬁtting of the FTIR
spectra in the region 1350–1600cm-1 was performed,
as it is visible form Fig. 5.
From the presentedFTIR results fourtypesofregions
of ν3 CO3
2– were observed: 1410–1430cm-1, 1430–
1460cm-1, 1460–1500cm-1 and 1500–1530cm-1. The
peaks position could be related with literature data as
follows: for B-type CO3HA at 1410cm-1 [54,55], 1415,
1417cm-1 [38,40,44,55,56], 1419, 1420–1423cm-1
[3,29,33,36,39,41,46,55,57], 1437cm-1 [55,57], 1449,
1455, 1458, 1459, 1460cm-1 [35,39–41,55–57], 1472,
1478cm-1 [3,29,47] and 1482, 1483, 1485, 1486cm-1
[47], and for A-type CO3HA at 1500, 1502, 1505–
1508cm-1 [46,60,62,63], 1512, 1516, 1517cm-1 [19],
1525cm-1 [64] and 1530, 1533cm-1 [61].
On the basis of the obtained results we can conclude
that B-type CO3HA is preferentially observed on the
surface of the soaked CSP samples. On the other hand,
A-type CO3HA was also detected. In addition, the band
posited at 1422 and 1437cm-1 could be ascribed to the
A/B-type of CO3HA [65]. Brieﬂy, we can summarize
that the synthesized and thermally treated at diﬀerent
temperatures CSP samples are in vitro bioactive in SBF
solution.
Figure 6 presents SEM images for the synthesized
and thermally treated CSP samples before soaking in
SBF solution. As it is seen, if the dried gel is treated at
1200°C (Fig. 6a) two type of particles can be observed:
i) spherically shaped with size in the range 1–3µm and,
ii) plate-like shaped with size in the range of 5µm.
Some authors concluded that the spherical particles are
characteristic for β-Ca2SiO4. For instance, Chrysaﬁ et
al. [66] postulated that these particles most probably
werethereasonforthestabilizationofβ-Ca2SiO4 atam-
bient temperature without the need of any stabilizers.
The particles with plate-like morphology could be as-
cribed to the Ca15(PO4)2(SiO4)6 in accordance with our
preliminary results [13]. Mostafa et al. [6] concluded
that thepreparationofceramicswiththis structurecould
be ascribed to the presence of silica in calcium phos-
phate structures as a function of the annealing temper-
ature. When the temperature of thermal treatment in-
creased, the quantity of particles with plate-like mor-
phology also increased (Figs. 6b,d). The depicted SEM
images are in a good agreement with XRD analysis of
the samples. As it can be seen, the SEM image of the
CSP 1400 sample is quite diﬀerent. On the right cor-
ner of the SEM image we can see the presence of small
globular particles with diﬀerent sizes in the range 0.5–
1.5µm. These particles could be related to CO3HA on
the surface of the synthesized sample. In accordance
with FTIR data presented at Fig. 2, partial carbonation
process is conducted.
Figures 7 and 8 show the SEM/EDX observations
of the soaked surface of the CPS samples in SBF so-
lution for 14 and 28 days. After 14 days of soaking,
the morphology of glass-ceramics surface changed dis-
tinctly with respect to that of the initial surface (Fig.
6). From the depicted SEM/EDX results (Fig. 7) it
is easily seen that the mineralized surface is covered
with a solid layer having small globular morphology
[3,67–69]. EDX analyses indicate the presence of large
amount of Ca and P with small amount of Si on the
soaked surface [33]. Furthermore, Na and Mg have also
been observed in traces only [3]. These ions are always
present in bones, teeth and other calciﬁed tissues. EDX
revealed that for the CSP 1200 sample Ca/(P+Si) ra-
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Figure 5. Curve-ﬁtting of the FTIR spectra of samples treated at diﬀerent temperatures and soaked in SBF for various times:
CSP 1200 for 14 (a) and 28 (e) days, CSP 1300 for 14 (b) and 28 (f) days, CSP 1400 for 14 (c) and 28 (g) days,
CSP 1500 for 14 (d) and 28 (h) days
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Figure 6. SEM of thermal treated CSP 1200 (a), CSP 1300 (b), CSP 1400 (c) and CSP 1500 (d) samples before in vitro test
tio (in wt.%) was 1.43. The observed ratio is less than
the stoichiometric value of 1.67 for pure HA structures.
This is because CO3
2– ions are located in PO4
3– sites
[39]. For CSP 1300 and CSP 1500 samples Ca/(P+Si)
ratio is 1.83 and 1.74, respectively. As it can be seen,
the presented ratio is much higher than the stoichiomet-
ric ratio. Deviation of Ca/(P+Si) ratio could be related
to the cation substitutions at the Ca2+ sites by Mg2+ or
Na+, substitution at PO4
3– sites by CO3
2– and/or SiO4
4–,
or a combination of these substitutions [70]. Finally,
CPS 1500 sample proved Ca/(P+Si) ratio of 1. 61 af-
ter 14 days of soaking [71].
After 28 days of immersion SEM (Fig. 8) no signiﬁ-
cant changes in the layer morphology was detected. As
it can be seen from the presentedSEM images,the glass
ceramic surface was coveredby a layer of spherical par-
ticles less than ∼10µm in diameter. On the other hand,
the covered surface is more compact and the size of
the visible macropores decreases [72]. EDX results re-
vealed that Ca/(P+Si) ratio decreased in the order CSP
1200 (1.65) > CSP 1300 (1.57) > CSP 1400 (1.40) >
CSP 1500 (1.28). From EDX results we can conclude
that HA, and Ca-def. HA was formed on the immersed
samples.
Figures 9 and 10 show the changes in the concen-
trations of Ca, P and Si in SBF solutions, measured by
ICP-AES, after soaking for 14 and 28 days. From the
presented ICP-AES results, it is obvious that the con-
centration of SBF solutions changed remarkably after
14 days. Compared with the quantity of these ions in
SBF solution (sample 1 in both ﬁgures), the Ca and Si
concentrations increased rapidly [73]. On the contrary,
the concentration of P decreased from 35mg/l in SBF
solution to <1mg/l in both solutions. After 28 days of
immersion (Fig. 10), the Ca concentrations increased,
while Si concentrationsdecreased.The increasing of Ca
ions with increasing of soaking time could be related to
a faster consumption of this ion, during the crystalline
carbonate apatite formation on the surface of the soaked
samples [23]. On the other hand, the decreasing of P
and Si concentrations during the soaking periods could
be ascribed to the consumption of these ions from SBF
solutions.
As it is known, the nucleation and growth of a crys-
talline apatite layer after soaking in SBF on CaO-SiO2
sol-gel glass-ceramics was proposed by Ebisawa et al.
[74]. Some authors concluded that an interexchangebe-
tween Ca ions of the sample and the solution H3O+
takesplace,givingrisetotheformationofSi-OHgroups
on the glass-ceramic surface that induce the apatite nu-
cleation [75]. Gandolﬁ et al. proved that reaction be-
tween Ca ions with H+ or H3O+ could form the aque-
ous mixing solution to form a solid-liquid interface
[76].Furthermore,thereactionbetweenCaandOH ions
gives Ca(OH)2 which creates high alkaline environment
[77]. On the basis of these hydration processes, cation
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Figure 7. SEM/EDX of CSP 1200 (a), CSP 1300 (b), CSP 1400 (c), and CSP 1500 (d) samples after in vitro test
in SBF for 14 days
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Figure 8. SEM/EDX of CSP 1200 (a), CSP 1300 (b), CSP 1400 (c), and CSP 1500 (d) samples after in vitro test
in SBF for 28 days
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Figure 9. ICP-AES for SBF (1), CSP 1200 (2), CSP 1300 (3),
CSP 1400 (4) and CSP 1500 (5) samples after
soaking in SBF for 14 days
Figure 10. ICP-AES for SBF (1), CSP 1200 (2), CSP 1300 (3),
CSP 1400 (4) and CSP 1500 (5) samples after
soaking in SBF for 28 days
exchangeincreasesthe OHconcentrationof theSBF so-
lution [77].Inaccordancewith Richardson[78],the sur-
face of calciumsilicate is attachedbyOH ions,resulting
in hydration of SiO4
4– groups in alkaline environment.
In our case this leads to the formation of C−S−H (cal-
cium silicate hydrate) phase on the surface of the im-
mersed particles [14]. C−S−H is a porous highly wa-
ter containing silicate gel layer which contains Si−OH
groups [78]. Then it could bind with Ca ions to produce
negatively charged SiO– groups [79]. These ions could
react with Ca ions to produce SiO– ···Ca2+ fragments
and form ACP [80].
On the basis of the obtained results we can conclude
that silicon doped carbonate containing hydroxyapatite
could be formed on the synthesized samples after in
vitro test in SBF solution for 14 and 28 days in static
conditions.
IV. Conclusions
The novel glass-ceramics in the CaO-SiO2-P2O5
system have been synthesized by a polystep sol-gel
method. After thermal treatment at 1200°C of the dried
samples, XRD proved the presence of β-Ca2SiO4 and
Ca15(PO4)2(SiO4)6. After increasing the temperature of
the thermal treatment to 1500°C, Ca15(PO4)2(SiO4)6
became a predominant phase. FTIR of the thermal
treated at diﬀerent temperatures glass-ceramics showed
the presence of basic absorption bands corresponding
to Si−O−Si and PO4
3– modes. On the other hand, the
presenceofbandsat∼1530–1360cm-1 andat∼840cm-1
leads us to conclude that the partial carbonation process
is conducted, i.e. the synthesized glass-ceramics must
be kept in a desiccator. SEM of the synthesized samples
depicts the presenceof particles with diﬀerent morphol-
ogy. The particles with plate-like shaped type could be
ascribed to Ca15(PO4)2(SiO4)6.
After in vitro test for bioactivity for 14 and 28 days
FRIR depictedthatA-, B-,andA/B-typeCO3HAcanbe
detected. Moreover, B-type CO3HA was preferentially
precipitated on the soaked surfaces. SEM proved that
the glass ceramic surfaces were covered by a layer of
spherical particles. ICP-AES measurements lead us to
conclude that silicon containing carbonate hydroxyap-
atite (Si−CO3HA) can be formed on the soaked surface.
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